Table 2. LDL-P across LDL density phenotype adjusted for potentially confounding covariates.
Covariate | Phenotype A, (Mean, n = 67) | 95% CI | Phenotype A/B (Mean, n = 56) | 95% CI | Phenotype B (Mean, n = 25) | 95% CI | p |
Unadjusted | 1075 | 972–1179 | 1109 | 995–1222 | 1308 | 1140–1475 | 0.052 |
age | 1062 | 959–1165 | 1125 | 1012–1238 | 1307 | 1139–1476 | 0.062 |
HDL-C | 1082 | 976–1189 | 1116 | 1002–1229 | 1276 | 1101–1450 | 0.18 |
ApoAI | 1060 | 995–1165 | 1126 | 1012–1240 | 1310 | 1138–1481 | 0.057 |
ln(TG) | 1106 | 1006–1025 | 1134 | 1028–1241 | 1171 | 1000–1242 | 0.81 |
LDL-C | 1038 | 979–1097 | 1161 | 1097–1226 | 1291 | 1194–1388 | 0.00005 |
non-HDL-C | 1054 | 994–1114 | 1169 | 1104–1234 | 1230 | 1133–1329 | 0.0034 |
HDL-C, non-HDL-C, ln(TG) | 1070 | 1009–1130 | 1155 | 1091–1219 | 1221 | 1118–1324 | 0.036 |
ApoB | 1087 | 1032–1141 | 1164 | 1104–1223 | 1154 | 1064–1245 | 0.14 |
TC/HDL-C | 1106 | 1022–1191 | 1143 | 1051–1235 | 1149 | 1007–1292 | 0.80 |
ApoB/ApoAI | 1117 | 1045–1190 | 1142 | 1063–1220 | 1122 | 1001–1244 | 0.89 |
TC/HDL-C, ln(TG) | 1112 | 1026–1199 | 1143 | 1051–1236 | 1131 | 983–1280 | 0.89 |
ApoB/ApoAI, ln(TG) | 1120 | 1046–1193 | 1142 | 1063–1222 | 1115 | 987–1242 | 0.89 |